MLAB mesalabs.com: Multiplikator Forward P/S

Logo grafis Mesa Labs Corp (MLAB)

Mesa Laboratories, Inc. (MLAB) is developing a recurring sales model for consumables, ensuring high margins. The forward P/S ratio confirms this growth, with the 0.30 metric serving as the target level. Financial stability is based on plants in the US and Europe, while strict FDA standards and patents for sterilization systems create significant barriers to entry for new market players.

mesalabs.com - Rasio kapitalisasi marang dodolan sing dikarepake MLAB (periode 04.07.2022 - 13.11.2026)

Rincian metrik lan analitis perusahaan Mesa Laboratories Corp. (MLAB)

- rega saiki lan proyeksi nilai saham:
Rega saham Mesa Labs|MLAB - Rata-rata rega prakiraan
- data kapitalisasi saham perusahaan:
Kapitalisasi pasar Mesa Laboratories Corp.|MLAB - Nilai Bisnis
- statistik nilai buku emiten:
Nilai Buku saben Saham Mesa Labs|MLAB - Pambiji Buku Bisnis|Rasio Kapitalisasi Pasar marang Nilai Buku mesalabs.com|MLAB - Gunggung Aset Perusahaan
- indikator total utang lan likuiditas perusahaan:
Total Utang marang Modal Mesa Laboratories, Inc.|MLAB - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Mesa Laboratories, Inc.|MLAB - Utang perusahaan|Utang marang nilai buku Mesa Laboratories Corp.|MLAB - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Mesa Labs|Likuiditas cepet mesalabs.com
- rincian asil keuangan lan kelipatan valuasi:
MLAB - Bathi resik taunan|Bathi mangsa ngarep Mesa Laboratories, Inc.|MLAB - Pangali P/E|Pangali Forward P/E Mesa Labs Corp|MLAB - Kapitalisasi marang bathi resik kanthi nimbang wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Mesa Laboratories Corp.|MLAB - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Mesa Labs|MLAB - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan mesalabs.com|MLAB - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Mesa Laboratories, Inc.
- indikator volume dodolan lan pendapatan:
MLAB - Volume dodolan perusahaan|Volume dodolan mangsa ngarep perusahaan Mesa Labs|MLAB - Kapitalisasi marang volume dodolan|Rasio rega marang prakiraan pendapatan Mesa Laboratories Corp.
Ringkesan analitik perusahaan:Mesa Labs (MLAB)
Sampel barang Mesa Laboratories, Inc.

To minimize risks during long-term asset ownership, it is necessary to align market value with the actual potential for cash flow generation. For Mesa Laboratories, Inc. (MLAB), which holds exclusive rights to sterilization indicators, the forward price-to-sales ratio reflects the relationship between the current price and projected sales, making it possible to determine whether the premium for its technological monopoly is justified or if the asset is speculatively overvalued.

Pesaing wigati

Multiplikator Forward P/S ABT (Abbott)|Thermo Fisher Scientific Inc. (TMO) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|GE Healthcare Corp - Multiplikator Forward P/S|MTD (Mettler Toledo Inc) - Kapitalisasi marang prakiraan pendapatan|WAT: Multiplikator Forward P/S|TECH - Rasio kapitalisasi marang dodolan sing dikarepake|BRKR (Bruker) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Azenta Inc (AZTA)|Multiplikator Forward P/S VREX|Multiplikator Forward P/S Semler (SMLR)|Rasio rega marang prakiraan pendapatan Butterfly Network, Inc. BFLY|quantum-si.com - Rasio rega marang prakiraan pendapatan|NNOX: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan QTRX (Quanterix Corp.)|MASS: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep CapsoVision (CV)|Rasio rega marang prakiraan pendapatan MaxCyte, Inc.|RPID - Prakiraan rega marang pendapatan|Multiplikator forward rega marang pendapatan SEER (Seer)|Multiplikator Forward P/S Hyperfine Inc (HYPR)|Multiplikator Forward P/S FONR (FONAR Corp)|Rasio kapitalisasi marang dodolan sing dikarepake Daxor Corp (DXR)|MDAI - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan VIVS|Aclarion, Inc. (ACON) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan Akoya Biosciences, Inc.|THMO (ThermoGenesis Holdings Inc.) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Talis Biomedical Corp TLIS|Rasio rega marang prakiraan pendapatan T2 Biosystems, Inc. (TTOO)